Whatever the challenge,
we find a way.
Clinigen group has a strong world network including Japan market, 3rd place in the world.
We are maximizing products life cycle for essential drugs, as a life cycle partner in JP market.
As a product life cycle partner, we are maximizing products life cycle for customers in Japan market.
*MAT: Marketing Authorization Transfer on post marketing products
Clnigen K.K. was established in 2013 (as Link Pharmaceuticals).
We achieved 7 MAT projects and one innovative product launch, and deliver 14 essential branded products to patients in Japan market.